cute coronary syndrome (ACS) is still one of the most important causes of death despite the development of new therapeutic methods. Cardiogenic shock (CS) after acute myocardial infarction (AMI) is known to occur in 5-10% of ACS cases and is associated with a high mortality rate. [1] [2] [3] Most cases of CS occur within the first few days of admission, thus the mortality rate could be reduced by early invasive treatment. 4 Primary or rescue percutaneous coronary intervention (PCI) with thrombolytic therapy is known to be effective in the management of AMI. 5, 6 It has been reported that an elevated concentration of Creactive protein (CRP) is a predictor of adverse outcomes after primary or rescue PCI, and is associated with high incidence of CS and complications. [7] [8] [9] [10] [11] [12] [13] [14] Tomoda et al reported that CRP was the only prognostic factor in AMI patients in terms of predicting major adverse cardiac events (MACE), such as recurrent myocardial infarction (MI), the need for target lesion revascularization (TLR) because of restenosis, or cardiac death. 12 However, there is little information available about the concentration of CRP in AMI with CS after primary PCI or on the correlation between CRP concentration and MACE. Thus, the aim of this study was to assess the predictive factors of in-hospital mortality to identify the MACE occurring during a long-term clinical follow-up of patients with AMI and CS after undergoing primary PCI. survived (group I: 64.2±10.6 years, M:F =94:27) and 26 died (group II: 68.1±10.0 years, M:F =14:12) during admission.
The diagnosis of AMI was based on the criteria of American College of Cardiology/American Heart Association (ACC/AHA) and the European Society of Cardiology. 15 A clinical diagnosis of CS was made if all the following criteria were present: (1) systolic blood pressure (BP) persistently less than 90 mmHg or if vasopressors were required to maintain a BP of more than 90 mmHg, (2) evidence of end organ hypoperfusion (eg, urine output less than 30 ml or cold/diaphoretic extremities or an altered mental status), and (3) clinical evidence of elevated left ventricular filling pressures (eg, pulmonary congestion on physical examination or chest X-ray). 16 
Clinical and Angiographic Analysis
Data from the enrolled patients were analyzed with respect to clinical characteristics, such as past medical history, family history, smoking, vital signs, physical and laboratory examinations, and electrocardiographic, echocardiographic, and coronary angiographic findings. Of the risk factors, hypertension was present if it had been diagnosed and treated elsewhere or if the systolic blood pressure was greater than 140 mmHg or the diastolic blood pressure exceeded 90 mmHg on more than 2 occasions after visit; diabetes mellitus was present if it had been diagnosed and treated elsewhere or as a fasting blood glucose ≥126 mg/dl after admission; hypercholesterolemia was present if it had been diagnosed and treated elsewhere or the fasting serum cholesterol concentration ≥200 mg/dl; a family history was defined as any family member with angina pectoris or MI or cerebrovascular or peripheral vascular disease.
Cardiac enzymes and biochemical markers such as CRP were checked on admission, followed by daily monitoring while in hospital. Based on diagnostic coronary angiography (CAG), the types of lesions were classified according to the ACC/AHA classification: 17 A and B1 were regarded as simple lesions, whereas B2 and C were considered as complex. Critical stenosis was defined as ≥75% diameter stenosis. The number, location, and characteristics of the target vessel and the presence of thrombus or calcifications were compared between the 2 groups, and the Thrombolysis In Myocardial Infarction (TIMI) score 18 for the infarct-related artery was calculated.
Emergency PCI was performed as soon as possible in patients who were able to undergo CAG (96±56 min after arrival at the Emergency Medical Center). Successful reperfusion was defined as TIMI 3 flow in the infarct-related artery after PCI and ≤25% residual stenosis.
The incidence of MACE, such as death, cerebrovascular accident, AMI, repeated PCI, and coronary artery bypass grafting (CABG), during hospitalization and after 6 months and 1 year of clinical follow-up.
Statistical Analysis
All data are presented as mean ± standard deviation. Nominal variables were analyzed using the chi-square test and various continuous variables were compared using the t-test and chi-square test. Differences were considered significant if the p-value was less than 0.05. Also, predictive factors were sought using binary logistic regression analysis after adjusting for age, sex, and the risk factors of coronary artery disease.
Results

Baseline Clinical Characteristics
No significant differences were observed in the risk factors of the 2 groups, other than age (64±11 vs 68±10, p=0.004), and group I had more male patients than group II (77.7% vs 53.8%, p=0.03). Mean left ventricular ejection Table 1 ).
Laboratory Findings
The concentrations of creatinine kinase (CK)-MB (140.6± 187.8 mg/dl vs 240.5±270.8 mg/dl, p=0.043), troponin (Tn)-I (27.6±11.8 ng/dl vs 63.1±59.7 ng/dl, p=0.34) and CRP (3.6±3.8 mg/dl vs 13.8±10.0 mg/dl, p<0.001) were lower in group I than group II (Table 2) .
CAG Findings
No significant differences in the CAG findings of the 2 groups was observed, other than group I had less cases of both frequent complex lesions (52% vs 88%, p=0.001) and total occlusion (43.8% vs 76.9%, p=0.001, Table 3 ).
Coronary Revascularization
With regard to procedural characteristics, there were no significant differences in door-to-needle time or door-toballoon time, but intra-aortic balloon pump (IABP) insertion was performed more frequently in group I (20.1% vs 8.7%, p=0.012), TIMI 3 flow after PCI was obtained more frequently in group I (76.0% vs 30.8%, p<0.001), and complications after PCI occurred less frequently in group I than group II (11.5% vs 34.6%, p=0.041, Table 4 ).
The concentration of CRP negatively correlated with LVEF ( =-0.180, p=0.029), preprocedural TIMI flow ( =-0.209, p=0.011) and post-procedural PCI ( =-0.498, p<0.001) by Pearson's correlation.
In group I, there were 5 cases of ventricular tachycardia (VT), 6 cases of no-reflow phenomenon, and 2 cases of ventricular septal defect, and 1 patient underwent emergency CABG for a recurrence of AMI. In group II, there were 6 cases of VT and 3 cases of no-reflow. According to binary logistic regression analysis, the factor most related to in-hospital mortality was TIMI flow <3 after PCI (p=0.02, odds ratio (OR) =1.3, Table 5 ).
Long-Term Clinical Follow-up
Among the survivors, there were 7 cases of recurrent MI and 10 cases of TLR, but no cases of cardiac death, during 6-month follow-up. After 1-year follow-up, there were 2 cases of recurrent MI, 10 cases of TLR, and 3 cases of cardiac death. The causes of death were sudden cardiac death in 2 cases and intractable VT in 1 case.
Event-Free Survival
At the end of the year of clinical follow-up, 89 patients (60.5%) had survived MACE-free. The patients who developed a MACE had a higher CRP (5.8±4.9 mg/dl vs 2.7± 2.1 mg/dl, p=0.003), more frequent multi-vessel involvement (70.6% vs 41.3%, p=0.018) and less than TIMI 3 flow after PCI (55.8% vs 81.6%, p=0.006). The occurrence of MACE during the 1-year follow-up period was associated with a CRP ≥1 mg/dl (p=0.002, OR =6.3) and low TIMI flow after coronary revascularization (p<0.001, OR =7.8, Table 6 ).
Discussion
CS resulting from AMI is a serious complication with a high mortality rate, 19 and although the incidence of CS has been reduced by early treatment, but it still remains high; for example, in the present study it was 14.7% overall (289/1,968 patients between 1999 and 2002) and despite having been much reduced since 1990, the in-hospital mortality rate was 17.6%.
The causes of CS after AMI are extensive infarction involving several vessels, left main stem (LMS) involvement, ventricular septal defect, extensive mitral regurgitation (MR) and cardiac rupture. 3, 6, 16, 19 In the present study, the cause of CS was extensive MI in 130 patients (88.4%), extensive MR in 11 patients (7.5%), LMS involvement in 4 patients (2.7%) and ventricular septal defect in 2 patients (1.4%).
Old age, diabetes mellitus, a previous MI, a large infarct as estimated as by cardiac enzyme assay, the presence of left anterior descending artery occlusion or multiple vessel disease, prolonged occlusion of an infarct-related artery, and decreased LVEF were also associated with CS. [20] [21] [22] Elevated CRP concentration is associated with a poor prognosis in ACS. [23] [24] [25] We previously reported that a high CRP concentration is related to a poor prognosis in patients with AMI and poor long-term clinical outcomes after primary or rescue PCI. 14, 26 In present study, the concentration of CRP was negatively correlated with LVEF, preprocedural TIMI flow and post-procedural PCI. No differences in risk factors such as hypertension, diabetes, and hypercholesterolemia, were observed, but old age, high concentrations of CK-MB, troponin-I, and CRP were associated with death after AMI complicated by CS. Our results suggested that a large infarct and severe inflammation of a coronary artery contributed to in-hospital death after CS.
Revascularization with primary or rescue PCI is important for the survival of AMI patients, especially in patients with CS. 27, 28 The SHOCK trial investigators 29 reported that early revascularization more effectively reduced mortality than medical therapy, so revascularization should be performed in all patients with CS after AMI as soon as possible. We previously reported that primary PCI reduced in-hospital mortality from 46.7% to 17.2%, 30 and in the present study the in-hospital mortality of the enrolled patients was 17.6%, which suggests that the early revascularization strategy significantly improved short-term survival; however, the moribund group, including the critical patients, were unable to undergo intensive invasive procedures, such as IABP insertion.
Recently, the TIME trial reported that patients aged 75 years or older with angina benefit more from revascularization than from optimal medical therapy in terms of symptom relief and quality of life. 31 Therefore, older patients should undergo an invasive assessment despite a high-risk profile, followed by revascularization if feasible.
The mortality rate for an early revascularization strategy depends on the door-to-needle time, the TIMI flow grade after revascularization, and whether 2 or more vessels or a left main stem lesion are involved. [32] [33] [34] [35] In the present study, there was no significant difference in door-to-balloon time, but the TIMI flow grade was significantly lower in the moribund patients, and they more often had complex lesions and/or total occlusion.
The use of IABP before primary PCI for AMI in all patients with CS is beneficial for patients with depressed left ventricular function. [36] [37] [38] [39] In the present study, more patients in the survivor group had IABP inserted. Kurisu et al reported that IABP was effective in patients with persistent ST elevation after PCI for AMI. 40 
Study Limitations
One limitation is the criteria used to diagnose CS. We did not perform a full diagnostic hemodynamic study, such as right-heart catheterization or measurement of cardiac output, because we wanted to recanalize the infarct-related artery as soon as possible. Another is that our study was a single-center and retrospective clinical study.
Conclusion
Establishing TIMI 3 flow by primary PCI may reduce the in-hospital mortality of patients with CS. A high concentration of CRP was identified as an additional predictive factor of long-term survival after primary PCI for AMI with CS.
